Global Patent Index - EP 1414862 A1

EP 1414862 A1 20040506 - ANTI-IDIOTYPIC ANTIBODIES OF HLA CLASS I MOLECULES AND THE USE THEREOF IN THE PREPARATION OF COMPOSITIONS THAT ARE DESIGNED TO INHIBIT VASCULAR ACTIVATION

Title (en)

ANTI-IDIOTYPIC ANTIBODIES OF HLA CLASS I MOLECULES AND THE USE THEREOF IN THE PREPARATION OF COMPOSITIONS THAT ARE DESIGNED TO INHIBIT VASCULAR ACTIVATION

Title (de)

ANTIIDIOTYPISCHE ANTIKÖRPER VON HLA KLASSE I MOLEKÜLEN UND DEREN VERWENDUNG ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN ZUR INHIBIERUNG DER VASKULÄREN AKTIVIERUNG

Title (fr)

ANTICORPS ANTI-IDIOTYPIQUES DE MOLECULES HLA DE CLASSE I ET LEUR UTILISATION POUR LA PREPARATION DE COMPOSITIONS DESTINEES A INHIBER L'ACTIVATION VASCULAIRE

Publication

EP 1414862 A1 20040506 (FR)

Application

EP 02772487 A 20020806

Priority

  • FR 0202813 W 20020806
  • FR 0110553 A 20010807

Abstract (en)

[origin: FR2828490A1] Anti-idiotypic antibodies (AAb) of a Class I human leucocyte antigen (HLA) molecule (I), and their fragments or derivatives, is new. Independent claims are also included for the following: (1) nucleic acid (II) comprising, or containing, a sequence that encodes AAb; (2) conjugate (III) of AAb with a therapeutic or diagnostic agent; and (3) determining (I) or AAb.

IPC 1-7

C07K 16/42; C12N 15/13; A61K 39/395; A61P 37/00; A61P 35/00; G01N 33/577; G01N 33/68

IPC 8 full level

A61P 9/10 (2006.01); A61P 19/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/06 (2006.01); C07K 16/42 (2006.01); C12N 15/13 (2006.01)

CPC (source: EP)

A61P 9/10 (2017.12); A61P 19/00 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/06 (2017.12); C07K 16/4258 (2013.01); A61K 2039/505 (2013.01)

Citation (search report)

See references of WO 03014163A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

DOCDB simple family (publication)

FR 2828490 A1 20030214; CA 2456287 A1 20030220; EP 1414862 A1 20040506; WO 03014163 A1 20030220

DOCDB simple family (application)

FR 0110553 A 20010807; CA 2456287 A 20020806; EP 02772487 A 20020806; FR 0202813 W 20020806